These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4082246)

  • 41. Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin.
    Yamamura S; Hamaguchi T; Ohoyama K; Sugiura Y; Suzuki D; Kanehara S; Nakagawa M; Motomura E; Matsumoto T; Tanii H; Shiroyama T; Okada M
    Epilepsy Res; 2009 Apr; 84(2-3):172-86. PubMed ID: 19268540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A; Eslamai MH
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.
    de Wolff FA; Peters AC; van Kempen GM
    Neuropediatrics; 1982 Feb; 13(1):10-3. PubMed ID: 6123089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo interaction of anticonvulsant drugs. The mathematical correlation of plasma levels of anticonvulsant drugs in epileptic patients.
    Abarbanel J; Herishanu Y; Rosenberg P; Eylath U
    J Neurol; 1978 May; 218(2):137-44. PubMed ID: 78974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug interactions during anticonvulsant therapy in childhood: diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepin and dipropylacetate.
    Windorfer A; Sauer W
    Neuropadiatrie; 1977 Feb; 8(1):29-41. PubMed ID: 321985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
    Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
    Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding parameters of phenytoin during monotherapy and polytherapy.
    Pospísil J; Perlík F
    Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):24-8. PubMed ID: 1348053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of acute and chronic terfenadine on free and total serum phenytoin concentrations in epileptic patients.
    Coniglio AA; Garnett WR; Pellock JH; Tsidonis O; Hepler CD; Serafin R; Small RE; Driscoll SM; Karnes HT
    Epilepsia; 1989; 30(5):611-6. PubMed ID: 2571498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenytoin-induced seizures: a paradoxical effect at toxic concentrations in epileptic patients.
    Osorio I; Burnstine TH; Remler B; Manon-Espaillat R; Reed RC
    Epilepsia; 1989; 30(2):230-4. PubMed ID: 2924747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salivary phenytoin levels in institutionalized epileptics.
    Hassell T; O'Donnell J; Pearlman J; Tesini D; Best H; Murphy T
    J Chronic Dis; 1983; 36(12):899-906. PubMed ID: 6655035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenytoin concentration elevation subsequent to ranitidine administration.
    Tse CS; Akinwande KI; Biallowons K
    Ann Pharmacother; 1993 Dec; 27(12):1448-51. PubMed ID: 8305773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.
    Pisani F; Fazio A; Artesi C; Russo M; Trio R; Oteri G; Perucca E; Di Perri R
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):126-7. PubMed ID: 1538217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid.
    Haidukewych D; Rodin EA; Zielinski JJ
    Ther Drug Monit; 1989; 11(2):134-9. PubMed ID: 2497562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man.
    Sjö O; Hvidberg EF; Naestoft J; Lund M
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):249-54. PubMed ID: 1233220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
    El Desoky E; Kandil MR; Afifi AH; Mostafa OA
    Pharmacol Res; 1999 Apr; 39(4):269-74. PubMed ID: 10208756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lamotrigine Drug Interactions in Combination Therapy and the Influence of Therapeutic Drug Monitoring on Clinical Outcomes of Adult Patients.
    Grundmann M; Koristkova B; Brozmanova H; Kacirova I
    Ther Drug Monit; 2017 Oct; 39(5):543-549. PubMed ID: 28682924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of carbamazepine, clonazepam, and phenytoin on seizure threshold in amygdala and cortex.
    Albright PS
    Exp Neurol; 1983 Jan; 79(1):11-7. PubMed ID: 6822249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time-dependent interaction between phenytoin and valproic acid.
    Riva R; Albani F; Contin M; Perucca E; Ambrosetto G; Gobbi G; Santucci M; Procaccianti G; Baruzzi A
    Neurology; 1985 Apr; 35(4):510-5. PubMed ID: 3920548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients.
    Privitera MD
    Ther Drug Monit; 1989 Nov; 11(6):647-51. PubMed ID: 2595745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Plasma levels of antiepileptic agents in the treatment of epilepsy].
    De Paiva VJ; Subirana A; Subirana M
    Arq Neuropsiquiatr; 1984 Sep; 42(3):209-14. PubMed ID: 6437382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.